CLNP023C12303
Clinical Trial Grant
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
June 1, 2023
End Date
February 3, 2026
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
June 1, 2023
End Date
February 3, 2026